2% Xylocaine DENTAL with Adrenaline (epinephrine) 1:80,000 New Zealand - English - Medsafe (Medicines Safety Authority)

2% xylocaine dental with adrenaline (epinephrine) 1:80,000

dentsply sirona (nz) limited - adrenaline acid tartrate 0.0227mg equivalent to 12.5 µg adrenaline;  ; lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous - solution for injection - active: adrenaline acid tartrate 0.0227mg equivalent to 12.5 µg adrenaline   lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - the product is indicated for the production of local nerve anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

LIGNOCAINE AND ADRENALINE Zimbabwe - English - Medicines Control Authority

lignocaine and adrenaline

datlabs private limited - adrenaline acid tartrate; lignocaine hydrochloride - injectable; injection - 0.4; 400mg/20ml

XYLOROLLAND 2% WITH ADRENALINE 1:80,000 lidocaine (lignocaine) hydrochloride 2% with adrenaline (epinephrine) 1:80,000 (as acid Australia - English - Department of Health (Therapeutic Goods Administration)

xylorolland 2% with adrenaline 1:80,000 lidocaine (lignocaine) hydrochloride 2% with adrenaline (epinephrine) 1:80,000 (as acid

acteon australia/new zealand - adrenaline (epinephrine) acid tartrate,lidocaine (lignocaine) hydrochloride monohydrate -

TRI-SOLFEN TOPICAL ANAESTHETIC & ANTISEPTIC SOLUTION FOR PAIN RELIEF IN LAMBS AND CALVES Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

tri-solfen topical anaesthetic & antiseptic solution for pain relief in lambs and calves

dechra veterinary products (australia) pty. ltd. - bupivacaine hydrochloride; lignocaine as lignocaine hydrochloride; adrenaline-l-acid tartrate-d; cetrimide - topical cream, ointment, paste, gel, lotion - bupivacaine hydrochloride anaesthetic active 4.2 g/l; lignocaine as lignocaine hydrochloride anaesthetic active 40.6 g/l; adrenaline-l-acid tartrate-d hormone active 24.8 mg/l; cetrimide ammonium-quaternary active 5.0 g/l - anaesthetics/analgesics - lamb with mulesing wound - post surgical pain

Xylocaine 1% with Adrenaline 1:100,000 New Zealand - English - Medsafe (Medicines Safety Authority)

xylocaine 1% with adrenaline 1:100,000

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline;  ; lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous; adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline; lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous - solution for injection - active: adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline   lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid as 2m solution for ph adjustment (ph 3.3-5.0) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 3.3-5.0) sodium metabisulfite water for injection active: adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid as 2m solution for ph adjustment nitrogen as nitrogen for injection sodium chloride sodium hydroxide as 2m solution for ph adjustment sodium metabisulfite water for injection

Xylocaine 1% with adrenaline (epinephrine) 1:100,000 ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine 1% with adrenaline (epinephrine) 1:100,000 ampoule

aspen pharmacare australia pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty 10 microgram/ml); lidocaine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections; sodium hydroxide; sodium metabisulfite - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block

2% XYLOCAINE DENTAL WITH ADRENALINE 1:80,000 2.2mL injection cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

2% xylocaine dental with adrenaline 1:80,000 2.2ml injection cartridge

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty 12.5 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium metabisulfite; sodium hydroxide - indications as at 25 july 2003 : lidocaine (lignocaine) solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine (lignocaine) solutions with adrenaline (epinephrine) are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

Norocaine Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

norocaine solution for injection

norbrook laboratories limited - lignocaine hydrochloride; adrenaline acid tartrate - solution for injection - percent volume/volume - lidocaine, combinations - horses - neurological preparations

2% XYLOCAINE DENTAL Australia - English - Department of Health (Therapeutic Goods Administration)

2% xylocaine dental

dentsply (australia) pty ltd - lignocaine hydrochloride; adrenaline acid tartrate -

XYLOCAINE 2.0% WITH ADRENALINE 1:80,000 5mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine 2.0% with adrenaline 1:80,000 5ml injection ampoule

aspen pharmacare australia pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty microgram/ml) - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.